Scholars Central

Conference abstractPublished 30 May 2019

Probiotics as immune modulators in prevention of intestinal infection

Authors: Aziz Koleilat

Makassed University General Hospital, Lebanon

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Use of probiotics may induce a barrier influence against common pathogens and antigens by activating macrophages, altering cytokines, increasing natural killer cell activity and/or increasing levels of immunoglobulins. Recognition of in vivo and immunomodulatory roles of probiotic bacteria is now promoting opportunities for use of these microorganisms in many fields e.g., inflammation, infection and atopy. The survival issues of probiotics are associated with their establishment in the competitive gut ecosystem. Since the generation of immunophysiological regulation in the gut depends on the establishment of indigenous microflora and on the therapeutic interventions based on the consumption of cultures of beneficial live microorganisms that act as probiotics. One of possible mechanisms of probiotics is promotion of a nonimmunologic gut defence barrier, which includes the normalization of increased intestinal permeability (dysbiosis) and gut microecology. The role and effect of probiotics in infant feeding, on the mucosal permeability and microbial flora composition and in turn on the stabilization of Th1/Th2 & IgE production has been tested. Another possible mechanism of probiotics is improvement of the intestine's immunologic barrier, particularly through intestinal immunoglobulin, alleviation of intestinal inflammatory reaction that promotes a gut-stabilizing effect. Many probiotics effects are mediated through immune regulation, particularly through balance control of proinflammatory and anti-inflammatory cytokines. So, probiotics can be used as innovative tools to alleviate intestinal inflammation, normalize gut mucosal dysfunction and down-regulate hypersensitivity reactions. There are differences that exist in the immunomodulatory effects of candidate probiotics bacteria. Specific immunomodulatory properties of probiotics bacteria should be characterized when developing clinical applications for extended target populations.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pediatrics & Therapeutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPediatrics & Therapeutics
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Aziz Koleilat”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels